Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2

Many anticancer drugs have serious adverse effects; therefore, it is necessary to target features specific to cancer cells to minimize the effects on healthy cells. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) was reported to be specifically enhanced in cancer. We confirmed the validity of MTH...

Descripción completa

Detalles Bibliográficos
Autores principales: Asai, Ayumu, Koseki, Jun, Konno, Masamitsu, Nishimura, Tatsunori, Gotoh, Noriko, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299143/
https://www.ncbi.nlm.nih.gov/pubmed/30582043
http://dx.doi.org/10.1016/j.heliyon.2018.e01021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299143/
https://www.ncbi.nlm.nih.gov/pubmed/30582043
http://dx.doi.org/10.1016/j.heliyon.2018.e01021

Ejemplares similares